Althea Pharma

What Althea Pharma does

Althea Pharma is an India-based pharmaceutical manufacturer founded in 2009, specializing in parenteral (injectable and infusion) products manufactured using Blow-Fill-Seal (BFS) technology. The company operates a corporate office in Mumbai and a manufacturing facility in Daman, India, and holds WHO-GMP certification supporting product registrations in 14+ countries across Africa, the Middle East/CIS, Latin America, and South-East Asia.

The company's core offering spans seven therapeutic categories: Anti-Infectives, Critical Care, Inhalants, Infusions/Injections, Sterile Diluents/Solvents, Anaesthetics, and Anti-Inflammatories. Products include both Large Volume Parenterals (100ml–500ml infusions) and Small Volume Parenterals (5ml–30ml injections). Manufacturing relies on imported, fully automated BFS machines supplied by Rommelag and Weiler, with virgin thermoplastic granules sourced from LyondellBasell, LG Chem, Borealis, and Dow. BFS packs are sterilized and leak-tested at 108°C for one hour in a closed container and are thermostable for distribution in high-temperature regions.

Althea Pharma operates a dual-channel business model: direct international exports to hospitals, clinics, and government health programs across emerging markets, alongside contract manufacturing for domestic Indian pharmaceutical companies. The company participates in international government tenders and has publicly identified expansion targets across Cameroon, Zambia, Zimbabwe, Malawi, Madagascar, Mauritius, Rwanda, Iraq, Jordan, Sri Lanka, Chile, Vietnam, and Malaysia. A development pipeline includes Erythropoietin prefilled syringes, Cetrorelix Acetate, Semaglutide, and Fondaparinux PFS injections, signaling a strategic shift from a volume-based to a value-based product portfolio.

Name

Althea Pharma

Legal name

Althea Pharma

Website

https://altheapharma.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Short description

Althea Pharma is an India-based pharmaceutical manufacturer specializing in parenteral injectables and infusions produced via Blow-Fill-Seal technology, exporting to 14+ emerging-market countries and providing contract manufacturing for domestic Indian pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF), Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Sterile parenteral manufacturing
• Generic injectable pharmaceuticals
• Blow-Fill-Seal production
• Pharmaceutical export services
• Aseptic drug manufacturing

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Pharmaceutical Export Sales: Althea Pharma generates revenue through export of generic pharmaceutical products including anesthetics, anti-infectives, anti-inflammatories, critical care drugs, inhalants, infusions, and sterile diluents to international markets across Africa, Middle-East, CIS, LatAM, and South-East Asia.
2. Contract Manufacturing for Domestic Market: The company manufactures products under contract for domestic Indian pharmaceutical companies, displaying logos of various domestic clients including Mediox and other unlisted clients.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Althea Pharma manufactures and supplies Blow-Fill-Seal (BFS) parenteral pharmaceutical products from a 200,000 sqft WHO-GMP certified, class 100 aseptic facility in India operating four fully automated production lines. Its portfolio covers large volume and small volume parenterals for the Indian domestic market and therapeutic categories—anaesthetics, anti-infectives, anti-inflammatories, critical care, inhalants, infusions and injections, and sterile diluents and solvents—for export to healthcare buyers across 14+ emerging-market countries.

Product overview

Althea Pharma is a pharmaceutical company specializing in parenteral products manufactured using Blow-Fill-Seal (BFS) technology. The company offers two primary product lines: Large Volume Parenterals (LVPs) including infusions in 100ml-500ml sizes and Small Volume Parenterals (SVPs) in 5ml-30ml sizes. Therapeutic categories include Anesthetics (Lidocaine, Sevoflurane, Isoflurane), Anti-Infectives (Fluconazole, Levofloxacin, Ciprofloxacin, Metronidazole, Linezolid), Anti-Inflammatories (Paracetamol, Paracetamol/Ibuprofen), Critical Care (Heparin, Enoxaparin, Calcium Gluconate, Dextrose), Inhalants (Salbutamol, Budesonide, Ipratropium), and Sterile Diluents/Solvents. Products are available for both domestic Indian market and export to Africa, Middle-East, CIS, LatAM, and Southeast Asia. The company also has a development pipeline including Erythropoietin, Cetrorelix Acetate, Semaglutide, and Fondaparinux prefilled syringe injections.

Differentiator

Problem solved

Functional benefit

Products and services

• Large Volume Parenterals (India Domestic) Sterile large-volume parenteral fluids manufactured via BFS aseptic processing and sold to institutional and distributor buyers within India's domestic market.
• Small Volume Parenterals (India Domestic) Sterile small-volume parenteral injectables manufactured via BFS aseptic processing and sold to institutional and distributor buyers within India's domestic market.
• Anaesthetic Injectables (Export) Sterile anaesthetic parenteral products manufactured via BFS and exported to healthcare providers across Africa, the Middle East, the CIS, Latin America, and South-East Asia.
• Anti-Infective Injectables (Export) Sterile anti-infective parenteral products manufactured via BFS and exported to institutional and government-tender buyers across 14+ emerging-market countries.
• Anti-Inflammatory Injectables (Export) Sterile anti-inflammatory parenteral products manufactured via BFS and exported to institutional and government-tender buyers across 14+ emerging-market countries.
• Critical Care Injectables (Export) Sterile critical-care parenteral products manufactured via BFS and exported to hospital and government-tender buyers across 14+ emerging-market countries.
• Inhalant Products (Export) Sterile inhalant parenteral products manufactured via BFS and exported to healthcare buyers across 14+ emerging-market countries.
• Infusions and Injections (Export) Sterile infusion and injection parenteral products manufactured via BFS and exported to institutional and government-tender buyers across 14+ emerging-market countries.
• Sterile Diluents and Solvents (Export) Sterile diluents and solvents manufactured via BFS and exported to healthcare buyers across 14+ emerging-market countries for reconstitution and administration use.

Quantifiable outcome

• Products registered and approved in 14+ countries across multiple regions
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• RommelagcoreTechnology or IntegrationRommelag is a key equipment supplier for Blow-Fill-Seal (BFS) manufacturing technology used in Althea's production lines. The company produces BFS units in imported fully automated machines with nil human intervention, ensuring high sterility standards.
• WeilercoreTechnology or IntegrationWeiler is a key equipment supplier for Blow-Fill-Seal (BFS) manufacturing technology. Althea uses Weiler equipment as part of their fully automated BFS production lines.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• B. Braun: Global medical/pharmaceutical company specializing in parenteral solutions, infusion therapy, and sterile injectables. Comparable to Althea in therapeutic and product category (LVPs, SVPs, sterile diluents) and global hospital-channel focus.
• Aurobindo Pharma: A leading Indian generic injectables manufacturer with global reach across emerging and regulated markets. Directly comparable to Althea as an Indian parenterals exporter, but at vastly greater scale and with US FDA-approved facilities.
• Fresenius Kabi: Global healthcare company focused on IV generic drugs, infusion solutions, and clinical nutrition. Direct overlap with Althea's LVP/SVP infusion portfolio and emerging-market distribution, but at multinational scale.
• Piramal Pharma: Diversified Indian pharmaceutical company with a complex generics injectables franchise and global sterile manufacturing. Comparable to Althea in injectable product mix, though with much broader geographic and segment reach.

Direct peers

• Gland Pharma: India-based specialty injectable pharmaceutical company focused on small- and large-volume parenterals, with strong US/EMEA presence. Closest direct peer to Althea in product category (sterile injectables/infusions) and contract manufacturing model.
• Bharat Serums and Vaccines: Indian specialty injectable/biologic company producing critical care, women's health, and biological products. Comparable to Althea in parenteral manufacturing focus and therapeutic overlap (Critical Care, Anaesthetics, anti-infectives).
• Claris Lifesciences: India-based sterile injectables manufacturer supplying LVPs, SVPs, and critical care products globally. Comparable to Althea in BFS/parenteral manufacturing footprint and emerging-market export focus.
• Maiva Pharma: India-based injectables CDMO/contract manufacturer specializing in sterile parenteral manufacturing. Comparable to Althea in parenteral contract manufacturing focus, BFS technology adoption, and small-to-mid scale.
• Akums Drugs & Pharmaceuticals: One of India's largest contract manufacturers of injectables, syrups, and sterile dosage forms. Comparable to Althea in domestic Indian contract manufacturing of parenterals and product portfolio breadth.

Others

• Rommelag: Global leader in Blow-Fill-Seal (BFS) machinery, supplying Althea's core production technology. Listed as an ecosystem/enabling peer given its role as Althea's BFS equipment supplier rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@AltheaPharmaPvtLtd
• LinkedInlinkedin.com/company/althea-pharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Althea Pharma